Alpine Associates Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Alpine Associates Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-223,000	Closed	-$70.6M	–	48
2023 Q4	$70.6M	Buy	+223,000	New	+$43.3M	3.62%	10

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Alpine Associates Management's KRTX Position: Q1 2024 in Review

Alpine Associates Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 223,000 shares — an estimated $70.6M sold.

Alpine Associates Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $70.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Alpine Associates Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Alpine Associates Management sold 223,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $70.6M.
Alpine Associates Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Alpine Associates Management's Karuna Therapeutics, Inc. Common Stock position peaked at $70.6M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Alpine Associates Management's 13F filing for Q1 2024, filed 9 May 2024.